Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.

Hdl Handle:
http://hdl.handle.net/10144/612817
Title:
Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.
Authors:
Mitnick, C D; Rodriguez, C A; Hatton, M L; Brigden, G; Cobelens, F; Grobusch, M P; Horsburgh, R; Lange, C; Lienhardt, C; Oren, E; Podewils, L J; Seaworth, B; van den Hof, S; Daley, C L; Gebhard, A C; Wares, F
Journal:
PloS One
Abstract:
There are numerous challenges in delivering appropriate treatment for multidrug-resistant tuberculosis (MDR-TB) and the evidence base to guide those practices remains limited. We present the third updated Research Agenda for the programmatic management of drug-resistant TB (PMDT), assembled through a literature review and survey.
Publisher:
Public Library of Science
Issue Date:
31-May-2016
URI:
http://hdl.handle.net/10144/612817
DOI:
10.1371/journal.pone.0155968
PubMed ID:
27223622
Submitted date:
2016-05-31
Language:
en
ISSN:
1932-6203
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorMitnick, C Den
dc.contributor.authorRodriguez, C Aen
dc.contributor.authorHatton, M Len
dc.contributor.authorBrigden, Gen
dc.contributor.authorCobelens, Fen
dc.contributor.authorGrobusch, M Pen
dc.contributor.authorHorsburgh, Ren
dc.contributor.authorLange, Cen
dc.contributor.authorLienhardt, Cen
dc.contributor.authorOren, Een
dc.contributor.authorPodewils, L Jen
dc.contributor.authorSeaworth, Ben
dc.contributor.authorvan den Hof, Sen
dc.contributor.authorDaley, C Len
dc.contributor.authorGebhard, A Cen
dc.contributor.authorWares, Fen
dc.date.accessioned2016-06-13T16:11:47Zen
dc.date.available2016-06-13T16:11:47Zen
dc.date.issued2016-05-31en
dc.date.submitted2016-05-31en
dc.identifier.citationProgrammatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda. 2016, 11 (5):e0155968 PLoS ONEen
dc.identifier.issn1932-6203en
dc.identifier.pmid27223622en
dc.identifier.doi10.1371/journal.pone.0155968en
dc.identifier.urihttp://hdl.handle.net/10144/612817en
dc.description.abstractThere are numerous challenges in delivering appropriate treatment for multidrug-resistant tuberculosis (MDR-TB) and the evidence base to guide those practices remains limited. We present the third updated Research Agenda for the programmatic management of drug-resistant TB (PMDT), assembled through a literature review and survey.en
dc.language.isoenen
dc.publisherPublic Library of Scienceen
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen
dc.titleProgrammatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.en
dc.identifier.journalPloS Oneen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.